Denmark vs Latin America and the Caribbean: Proportion of the target population who received a 3rd dose of
Denmark
96.0%
in 2024
Latin America and the Caribbean
76.0%
in 2024
Denmark rank
16th
Latin America and the Caribbean rank
17th
Proportion of the target population who received a 3rd dose of over time
- Denmark
- Latin America and the Caribbean
How they compare
Denmark currently reports 96.0% against 76.0% in Latin America and the Caribbean, a difference of 20.0%.
That makes Denmark's figure about 1.3 times Latin America and the Caribbean's.
Across all 16 years both countries report, Denmark has been ahead every year.
Denmark ranks 16th and Latin America and the Caribbean ranks 17th of 157 countries.
Denmark has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Latin America and the Caribbean | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.0% | 11.0% | 75.0% | Denmark |
| 2010s | 93.3% | 71.6% | 21.7% | Denmark |
| 2020s | 96.2% | 73.4% | 22.8% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Denmark or Latin America and the Caribbean?
- Denmark, at 96.0% against 76.0% in Latin America and the Caribbean as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Denmark and Latin America and the Caribbean?
- 20.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Latin America and the Caribbean?
- 16 years are reported by both, from 2009 to 2024.
- How do Denmark and Latin America and the Caribbean rank globally for proportion of the target population who received a 3rd dose of?
- Denmark ranks 16th and Latin America and the Caribbean ranks 17th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.